Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment
Condition:   Hyperparathyroidism; Secondary, Renal Interventions:   Drug: Cinacalcet Tablets;   Drug: calcitriol Sponsors:   Min-Sheng General Hospital;   Taipei Medical University Shuang Ho Hospital;   Taipei Medical University;   En Chu Kong Hospital;   National Taiwan University;   Taichung Tzu Chi Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2020 Category: Research Source Type: clinical trials